GynSuite is a unified, guideline-switchable gynecologic ultrasound calculator and decision-support hub. Eight integrated modules — endometrium, adnexal mass, fibroids, adenomyosis, Müllerian anomalies, PCOS & ovarian reserve, early pregnancy & ectopic workup, and systematic endometriosis (IDEA) mapping — each deliver an immediate Quick verdict or an expanded Explore view with feature checklists, reference diagrams, and teach blocks. Switch the guideline framework at the top to re-render every decision with ACR, SRU, IOTA, ACOG, NICE, ESHRE-ESGE, ASRM, FIGO, IDEA, MUSA, or Rotterdam 2023 thresholds. Use it as a daily bedside reference or a full reporting companion.

1 Pick a module

Tabs across the top — endometrium through endometriosis. Deep-link friendly (#endo, #adnexal, #fibroids, …).

2 Quick vs. Explore

Quick mode gives a compact input → single verdict. Explore surfaces the full checklist, teach blocks, diagrams, and case scenarios.

3 Guideline switch

Decisions re-render with the chosen framework's thresholds and citations. Ideal for tech, radiologist, obgyn, or reproductive-endo workflows.

4 Report rail

Right-side summary aggregates findings across every module. Copy, print, or reset the whole case.

Endometrium

Thickness, pattern and vascularity with guideline-switched interpretation — premenopausal phase-aware, postmenopausal biopsy triggers, HRT and tamoxifen overlays.

Measurements & status

Sagittal midline, widest anterior-posterior, excluding fluid
Try a case:

Interpretation

Guideline: ACR / AIUM · ACOG 2018

Teaching · endometrial thresholds

  • Symptomatic PMB: double-layer ET ≤ 4 mm has <1% risk of endometrial cancer — negative likelihood ratio 0.04. ET ≥ 5 mm triggers sampling. (ACOG CO 734, 2018; AIUM 2018)
  • Asymptomatic PMB: no universally agreed threshold. Smith-Bindman 2009 proposed ET > 11 mm (1:4 risk) as a reasonable cut-off for biopsy.
  • HRT effect: sequential regimens cause cyclical thickening; always measure in the estrogen-only phase. Continuous HRT → atrophic pattern expected.
  • Tamoxifen: cystic sub-endometrial changes common; saline-infusion sonohysterography preferred over ET alone. Symptomatic patient always gets biopsy regardless of ET.
  • Premenopausal: thickness alone is not diagnostic — phase, pattern and vascularity matter. Focal lesions + color score 3–4 → SIS.
Midline sagittal uterus — endometrial double-layer AP measurement technique bladder ET (mm) double-layer AP endo–myo → endo–myo fundus cervix endometrial cavity · midline echo myometrium functional layer myometrium midline echo
Fig 1 · Midline sagittal endometrial stripe. Measure the double-layer AP at the widest point perpendicular to the midline echo, excluding intracavitary fluid (if fluid present, measure each layer separately and sum).